Stock Chart

HLN

$9.09 -0.11%
Score: 50.3 BUY
Pro
Screener
Vol: 0.78x (vs SPY: 1.1x | vs QQQ: 1.1x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Nov 12, 2026
Bear Pennant weak / forming — below our quality gate quality 48/100
A Bear Pennant is taking shape but hasn't passed our quality gate (60/100), so no projected path or levels are shown — only the forming rails on the chart below.
Historically breaks down 70% of the time (n=1,730). Measured-move targets failed our backtest — none shown.
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About HLN - Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are …

Key Statistics

Market Cap $40B
P/E Ratio 18.57
Dividend Yield 0.02%

This HLN stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track HLN's price movements with trendlines, gamma walls, and key support/resistance levels.